Cutting edge: Can diabetes medicine metformin improve Covid-19 outcomes?

 

Although this study was conducted by the University of Minnesota, several studies have reported favourable outcomes in Covid-19 patients who were on Metformin. Another analysis from the US published earlier this year showed 0.83 per cent of people died of Covid-19 in the group that was on Metformin as compared to 4.02 per cent in the group that wasn’t

Although the diabetes medicine, Metformin, did not prevent hypoxia or low oxygen saturation in patients with Covid-19, it did result in fewer emergency room visits, hospitalisations and deaths due to the pandemic, according to a recent study by researchers from the University of Minnesota published in the New England Journal of Medicine.